Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Can a lung cancer genomic profile predict if the tumor will recur?

April 26, 2017genomic lung cancer predict profile recur tumor

0

Posted

Can a lung cancer genomic profile predict if the tumor will recur?

1 Answer

0

Posted

The Lung Metagene Score (LMS) may be able to determine recurrence risk. Initial results suggest that it can identify NSCLC tumors that are likely to recur. However, this tool is still under development, and it is only available to doctors and patients for the CALGB 30506 clinical trial. This trial opened across the United States in March 2009. Click here for information about locations for this trial. For information about this trial at Duke, call 919-668-6498 to speak to a member of the Lung Cancer Genomics Clinical Trials Team.